A Phase I Trial of Immunocytokine HU14.18-IL2 in Children with Recurrent or Refractory Neuroblastoma and Other GD2 Positive Malignancies: A Study of the Children's Oncology Group
Osenga, K, Hank, J, Albertini, M, Gan, J, Sternberg, A, Seeger, R, Matthay, K, Reynolds, P, Krailo, M, Adamson, P, Reisfeld, R, Gillies, S, Sondel, PVolume:
27
Language:
english
Journal:
Journal of Immunotherapy
DOI:
10.1097/00002371-200411000-00198
Date:
November, 2004
File:
PDF, 73 KB
english, 2004